197 related articles for article (PubMed ID: 37255415)
1. A Comparative Study of Neuroendocrine Heterogeneity in Small Cell Lung Cancer and Neuroblastoma.
Cai L; DeBerardinis RJ; Xie Y; Minna JD; Xiao G
Mol Cancer Res; 2023 Aug; 21(8):795-807. PubMed ID: 37255415
[TBL] [Abstract][Full Text] [Related]
2. Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities.
Simbolo M; Centonze G; Ali G; Garzone G; Taormina S; Sabella G; Ciaparrone C; Mafficini A; Grillo F; Mangogna A; Volante M; Mastracci L; Fontanini G; Pilotto S; Bria E; Infante M; Capella C; Rolli L; Pastorino U; Milella M; Milione M; Scarpa A
ESMO Open; 2022 Feb; 7(1):100308. PubMed ID: 34952268
[TBL] [Abstract][Full Text] [Related]
3. Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer.
Cai L; Liu H; Huang F; Fujimoto J; Girard L; Chen J; Li Y; Zhang YA; Deb D; Stastny V; Pozo K; Kuo CS; Jia G; Yang C; Zou W; Alomar A; Huffman K; Papari-Zareei M; Yang L; Drapkin B; Akbay EA; Shames DS; Wistuba II; Wang T; Johnson JE; Xiao G; DeBerardinis RJ; Minna JD; Xie Y; Gazdar AF
Commun Biol; 2021 Mar; 4(1):314. PubMed ID: 33750914
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles from non-neuroendocrine SCLC cells promote adhesion and survival of neuroendocrine SCLC cells.
Jimenez L; Stolzenbach V; Ozawa PMM; Ramirez-Solano M; Liu Q; Sage J; Weaver AM
Proteomics; 2024 Jun; 24(11):e2300030. PubMed ID: 37926756
[TBL] [Abstract][Full Text] [Related]
5. Molecular Subtypes of High-Grade Neuroendocrine Carcinoma (HGNEC): What is YAP1-Positive HGNEC?
Kawai H; Matsuoka R; Ito T; Matsubara D
Front Biosci (Landmark Ed); 2022 Mar; 27(3):108. PubMed ID: 35345340
[TBL] [Abstract][Full Text] [Related]
6. Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes.
Zhang W; Girard L; Zhang YA; Haruki T; Papari-Zareei M; Stastny V; Ghayee HK; Pacak K; Oliver TG; Minna JD; Gazdar AF
Transl Lung Cancer Res; 2018 Feb; 7(1):32-49. PubMed ID: 29535911
[TBL] [Abstract][Full Text] [Related]
7. Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer.
Fushimi A; Morimoto Y; Ishikawa S; Yamashita N; Bhattacharya A; Daimon T; Rajabi H; Jin C; Hagiwara M; Yasumizu Y; Luan Z; Suo W; Wong KK; Withers H; Liu S; Long MD; Kufe D
Mol Cancer Res; 2022 Sep; 20(9):1379-1390. PubMed ID: 35612556
[TBL] [Abstract][Full Text] [Related]
8. Application of Small Cell Lung Cancer Molecular Subtyping Markers to Small Cell Neuroendocrine Carcinoma of the Cervix: NEUROD1 as a Poor Prognostic Factor.
Kim G; Kim M; Nam EJ; Lee JY; Park E
Am J Surg Pathol; 2024 Mar; 48(3):364-372. PubMed ID: 37981832
[TBL] [Abstract][Full Text] [Related]
9. Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer.
Lu Y; Li H; Zhao P; Tian L; Liu Y; Sun X; Cheng Y
Sci Rep; 2024 Feb; 14(1):2884. PubMed ID: 38311608
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and prognostic implications of ASCL1 expression in surgically resected small cell lung cancer.
Wei J; Liu L; Guo Y; Zhang J; Wang X; Dong J; Xing P; Ying J; Yang L; Li J
Thorac Cancer; 2021 Jan; 12(1):40-47. PubMed ID: 33191657
[TBL] [Abstract][Full Text] [Related]
11. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line.
Watanabe H; Takahashi T; Ueda R; Utsumi KR; Sato T; Ariyoshi Y; Ota K; Obata Y; Takahashi T
Cancer Res; 1988 May; 48(9):2544-9. PubMed ID: 2833350
[TBL] [Abstract][Full Text] [Related]
12. POU2F3: A Sensitive and Specific Diagnostic Marker for Neuroendocrine-low/negative Small Cell Lung Cancer.
Wang Y; Jin Y; Shen X; Zheng Q; Xue Q; Chen L; Lin Y; Li Y
Am J Surg Pathol; 2023 Sep; 47(9):1059-1066. PubMed ID: 37357936
[TBL] [Abstract][Full Text] [Related]
13. Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer.
Patel AS; Yoo S; Kong R; Sato T; Sinha A; Karam S; Bao L; Fridrikh M; Emoto K; Nudelman G; Powell CA; Beasley MB; Zhu J; Watanabe H
Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33514539
[TBL] [Abstract][Full Text] [Related]
14. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.
Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T
Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131
[TBL] [Abstract][Full Text] [Related]
15. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
[TBL] [Abstract][Full Text] [Related]
16. Colony‑stimulating factor CSF2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑STAT3/MYC pathway.
Li H; Zhong R; He C; Tang C; Cui H; Li R; Liu Y; Lan S; Cheng Y
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35583004
[TBL] [Abstract][Full Text] [Related]
17. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
[TBL] [Abstract][Full Text] [Related]
18. Family matters: How MYC family oncogenes impact small cell lung cancer.
Brägelmann J; Böhm S; Guthrie MR; Mollaoglu G; Oliver TG; Sos ML
Cell Cycle; 2017 Aug; 16(16):1489-1498. PubMed ID: 28737478
[TBL] [Abstract][Full Text] [Related]
19. Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.
Pongor LS; Schultz CW; Rinaldi L; Wangsa D; Redon CE; Takahashi N; Fialkoff G; Desai P; Zhang Y; Burkett S; Hermoni N; Vilk N; Gutin J; Gergely R; Zhao Y; Nichols S; Vilimas R; Sciuto L; Graham C; Caravaca JM; Turan S; Tsai-Wei S; Rajapakse VN; Kumar R; Upadhyay D; Kumar S; Kim YS; Roper N; Tran B; Hewitt SM; Kleiner DE; Aladjem MI; Friedman N; Hager GL; Pommier Y; Ried T; Thomas A
Cancer Discov; 2023 Apr; 13(4):928-949. PubMed ID: 36715552
[TBL] [Abstract][Full Text] [Related]
20. Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity.
Udyavar AR; Wooten DJ; Hoeksema M; Bansal M; Califano A; Estrada L; Schnell S; Irish JM; Massion PP; Quaranta V
Cancer Res; 2017 Mar; 77(5):1063-1074. PubMed ID: 27932399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
